On one hand, it appears that newly diagnosed CP patients do not display significantly lower levels of SETD2 protein than those detectable in HD, independently of whether they will later progress to BC—although only four diagnosis/progression samples were available for paired analysis. This evidence concerns the gene SETD2 and Huntington disease.